Figure 2.

Protective effects of the TSAV pretreatment on CCl₄-induced liver damage. Histological examination was performed under a light microscope (original magnification: ×100) with HE staining on liver tissues. Group I: control; Group II: CCl₄; Group III: TSAV 50 mg/kg + CCl₄; Group IV: TSAV 100 mg/kg + CCl₄; Group V: TSAV 200 mg/kg + CCl₄; Group VI: silymarin 200 mg/kg + CCl₄. Blue, green, and black arrows indicate cell necrosis, inflammatory infiltration, and nuclear pyknosis, respectively.